文献速递心力衰竭与心肌病血脂与心血管预防

嗜酸性心肌炎的临床特征、治疗与结局

Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

该研究系统筛查MEDLINE和EMBASE截至2017年6月的443篇文献,纳入179例组织学确诊的嗜酸性心肌炎住院患者。中位年龄41岁,呼吸困难最常见(59.4%),外周血嗜酸性粒细胞增多占75.9%,中位左室射血分数35%。住院死亡率为22.3%,超敏反应型最高(36.1%,p=0.026)。

要点

  • 嗜酸性心肌炎急性期预后差,住院死亡率达22.3%。
  • 超敏反应型住院死亡率最高(36.1%,p=0.026)。
  • 约65%病例可识别相关疾病,特发性或未定义型占35.7%。

核心结论

  • 嗜酸性心肌炎急性期预后差,住院死亡率为22.3%,尽管发表偏倚可能高估死亡率。

研究设计与样本

  • 系统检索MEDLINE和EMBASE截至2017年6月的443篇文献,纳入179例组织学确诊的嗜酸性心肌炎住院患者进行回顾性分析。

主要发现

  • 中位年龄41岁(四分位距27至53岁),男女患病率相似,儿童病例(≤16岁)占10.1%。
  • 就诊时主要症状为呼吸困难(59.4%),外周血嗜酸性粒细胞增多占75.9%,中位左室射血分数35%(四分位距25%至50%)。
  • 最常见相关疾病为超敏反应(34.1%)和嗜酸性肉芽肿性多血管炎(12.8%),特发性或未定义型占35.7%。
  • 77.7%患者接受类固醇治疗,16.8%患者(n=30)使用临时机械循环支持。
  • 住院死亡22.3%(n=40),超敏反应型死亡率最高(36.1%,p=0.026)。

临床怎么用

  • 对组织学确诊的嗜酸性心肌炎患者,应警惕急性期高死亡风险,尤其超敏反应型。
  • 多数患者接受类固醇治疗,部分需临时机械循环支持,但具体方案需个体化。

局限性

  • 发表偏倚可能导致死亡率被高估。
  • 缺乏大规模病例系列或临床试验,证据基于已发表病例的系统回顾。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Eosinophilic myocarditis (EM) is an acute life-threatening inflammatory disease of the heart. Neither large case series nor clinical trials on this specific myocarditis have been reported. OBJECTIVES: Based on a systematic revision of all published histologically proven cases, this study aimed to describe the clinical presentation, treatment, and outcome of EM. METHODS: The study screened 443 manuscripts in MEDLINE and EMBASE on cases of EM published until June 2017. The authors identified 264 patients and included in the main analysis 179 patients admitted to hospital with histologically proven EM. RESULTS: Median age was 41 years (interquartile range: 27 to 53 years) with similar prevalence in both sexes; pediatric cases (≤16 years of age) accounted for 10.1%. The main symptom at presentation was dyspnea (59.4%), with peripheral eosinophilia observed in 75.9%. Median left ventricular ejection fraction at presentation was 35% (interquartile range: 25% to 50%). The disorders most frequently associated with EM were hypersensitivity and eosinophilic granulomatosis with polyangiitis, which accounted for 34.1% and 12.8% of cases, respectively, whereas idiopathic or undefined forms accounted for 35.7% of cases. Steroids were administered in 77.7% of patients. A temporary mechanical circulatory support (n = 30) was instituted in 16.8% of patients. In-hospital death was 22.3% (n = 40), with the highest occurrence in the hypersensitivity form (36.1%; p = 0.026). CONCLUSIONS: EM has a poor prognosis during the acute phase, despite a publication bias that could have led to an overestimation of mortality. Associated conditions are identified in approximately 65% of cases. Specific trials and multicenter registries are needed to provide evidence-based treatments to improve in-hospital outcome.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Brambatti M, Matassini MV, Adler ED, et al. Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes. J Am Coll Cardiol. 2017. PMID: 29096807. doi:10.1016/j.jacc.2017.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。